View Clinical Trial (Medical Research Study)

Perceptions Regarding Investigational Screening for Memory Problems in Primary Care - NCT00759252-46202(Clinical Trial 243309)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Indianapolis
State:  
IN
Zip Code: 46202
Conditions: Dementia
Purpose: The purpose of this study is to conduct a cross-sectional survey of primary care patients to better understand their perceptions of the risks and benefits of a screen and subsequent diagnostic confirmation of dementia.
Study summary: The Health Belief Model was used to explore the public's acceptance or enthusiasm for early recognition of dementia. Based on this model, prior research and clinical experiences, and a systematic literature review, the PRISM-PC instrument was developed. The PRISM-PC items seek to capture both the patient's acceptance of dementia screening and the patient's perception of potential harms and benefits of such screening. The instrument includes questions regarding screening by performance-based questionnaires, blood tests, or brain imaging. The PRISM-PC instrument includes 50 items that are organized into 8 sets of questions that cover the following areas: A) Prior experience with AD (5 items) B) Acceptance of screening for AD (6 items) C) Acceptance of screening for other conditions (2 items) D) Benefits of screening for AD (9 items) E) Stigma of screening for AD (10 items) F) Impact of screening for AD on independence (6 items) G) Suffering of screening for AD (4 items) H) Demographics (7 items) Excluding section A and H (prior experience with AD and demographics), each item of the six other sections is rated on a 5-point Likert scale (strongly agree, agree, don't know, disagree, and strongly disagree). Based on the previous PRISM-PC pilot study (a survey response rate of 80%) and the Dementia screening and diagnosis study (screening acceptance rate of 90%, positive dementia screening rate of 20% among participants aged 70 and older, and dementia diagnostic acceptance rate of 50%), a total of 1,500 volunteers will be approached. A random selection of 200 participants will be re-administered the questionnaire within one week to test the short-term temporal stability of their responses (test-retest).
Criteria: Inclusion Criteria: - Aged 65 and older - At least one office visit to their primary care physician within the last year - No chart-based diagnosis of dementia or memory problem - Willing to sign a consent form to participate in the study Exclusion Criteria: - Does not speak English - Too hearing-impaired to hear the informed consent statement or the survey - Severe mental illness based on the patient's electronic medical charts
Study is available at: Indiana University Medical Group
Indianapolis, IN 46202
United States

Primary Contact:
Malaz A. Boustani, MD, MPH
Email: mboustani@regenstrief.org
Phone: 317-423-5633

Secondary Contact:
Malaz Boustani, MD, MPH
Email: mboustani@regenstrief.org
Phone: 317-423-5633
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.